Zhendong Pharmacy(SZ:300158)2023-05-08 12:08Group 1: Company Overview and Shareholding - Shanxi Zhendong Pharmaceutical Co., Ltd. holds a 54% stake in Aloe King Wine Industry, with no actual investment made yet [1] - The company is still planning its related liquor business [1] Group 2: Market Performance and Stock Price - The company's stock price has halved, influenced by macroeconomic conditions, industry policies, and investor sentiment [1] - Management is committed to enhancing operational management to create long-term value for investors [2] Group 3: Product Sales and Marketing - Sales expenses for Dafixin, the company's main OTC product, are high due to advertising, promotion, and personnel costs [2] - Dafixin's market share reached 42.34% in 2022, ranking second in sales volume [3] - The product's sales revenue for 2022 was 425 million yuan [3] Group 4: Marketing Strategies - The company utilized over 1,200 channel partners and covered 72,000 terminal markets in 2022 [2] - Marketing efforts included significant advertising campaigns in major cities, reaching over 2.5 billion people [2] Group 5: Regulatory Compliance and Governance - The company acknowledges issues in governance and internal controls, actively working on rectification measures following regulatory penalties [4] - There is a commitment to enhance compliance with securities laws and improve information disclosure quality [4]